全文获取类型
收费全文 | 958790篇 |
免费 | 58492篇 |
国内免费 | 1076篇 |
专业分类
耳鼻咽喉 | 12618篇 |
儿科学 | 31633篇 |
妇产科学 | 25015篇 |
基础医学 | 157641篇 |
口腔科学 | 25277篇 |
临床医学 | 83760篇 |
内科学 | 176725篇 |
皮肤病学 | 22454篇 |
神经病学 | 66927篇 |
特种医学 | 35191篇 |
外国民族医学 | 116篇 |
外科学 | 142132篇 |
综合类 | 15680篇 |
现状与发展 | 2篇 |
一般理论 | 219篇 |
预防医学 | 71467篇 |
眼科学 | 22529篇 |
药学 | 74388篇 |
1篇 | |
中国医学 | 2015篇 |
肿瘤学 | 52568篇 |
出版年
2018年 | 9885篇 |
2016年 | 8250篇 |
2015年 | 9189篇 |
2014年 | 12417篇 |
2013年 | 18907篇 |
2012年 | 26672篇 |
2011年 | 29186篇 |
2010年 | 16990篇 |
2009年 | 15670篇 |
2008年 | 27417篇 |
2007年 | 29778篇 |
2006年 | 29584篇 |
2005年 | 28256篇 |
2004年 | 27592篇 |
2003年 | 26541篇 |
2002年 | 25833篇 |
2001年 | 43313篇 |
2000年 | 44762篇 |
1999年 | 36849篇 |
1998年 | 9963篇 |
1997年 | 8522篇 |
1996年 | 8833篇 |
1995年 | 8208篇 |
1994年 | 7508篇 |
1992年 | 27775篇 |
1991年 | 28980篇 |
1990年 | 29109篇 |
1989年 | 28275篇 |
1988年 | 25974篇 |
1987年 | 25733篇 |
1986年 | 24150篇 |
1985年 | 23123篇 |
1984年 | 17251篇 |
1983年 | 14692篇 |
1982年 | 8032篇 |
1981年 | 7342篇 |
1979年 | 16679篇 |
1978年 | 11999篇 |
1977年 | 9906篇 |
1976年 | 9959篇 |
1975年 | 11678篇 |
1974年 | 13494篇 |
1973年 | 12973篇 |
1972年 | 12204篇 |
1971年 | 11741篇 |
1970年 | 10928篇 |
1969年 | 10361篇 |
1968年 | 9780篇 |
1967年 | 8769篇 |
1966年 | 7826篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
As many as 60 patients with combined pathologies (chronic hepatitis (CH) and chronic non-calculous cholecystitis (CNCC)) were examined, and 20 healthy subjects were included in the control group. The efficacy of Essliver Forte for patients with chronic non-calculous cholecystitis combined with chronic hepatitises (both viral hepatitis and steatohepatitis) was assessed on the basis of clinical, biochemical and bacteriological criteria. Essliver Forte was found to improve the clinical and biochemical parameters of the functional liver condition, bile biochemical characteristics and intestinal microbiocenosis in patients with combined pathologies. The positive clinical effect is most evident for patients with chronic non-calculous cholecystitis and chronic steatohepatitis (both alcohol and non-alcohol). Essliver Forte can be recommended for treatment of patients with combined pathologies. 相似文献
995.
996.
K. OKAMURA I. KOBAYASHI K. MATSUO T. KIYOSHIMA K. YAMAMOTO A. MIYOSHI & H. SAKAI 《Histopathology》1997,31(6):540-548
Aims:
The purpose of this study is to examine the relationship between immunohistochemical localization of cathepsin D (CD), proliferating cell nuclear antigen (PCNA) and epidermal growth factor receptor (EGF-R) in 65 cases of breast carcinoma in Japanese women and traditional prognostic factors such as histological grade, lymph node status, mitotic rate and clinical stage, in order to possibly identify some indicator(s) that may be specifically associated with prognosis.
Methods and results:
Serial sections of 5-μm thick were cut from the archival formalin-fixed, paraffin-embedded tissue blocks, and processed for CD, PCNA and EGF-R immunostaining. The results were analysed by computer-based image analysis system. All samples showed a positive immunoreaction for cathepsin D in both the parenchyma and stroma. However, the staining area and intensity varied from cell to cell in the parenchyma and stroma as well as among samples. Subsequently, the evaluation of immunostaining for CD was separately performed in both the parenchyma and stroma (CDpar and CDstr, respectively) and the combination of both components (CDtotal). PCNA and EGF-R showed positive immunostaining almost exclusively in the parenchymal component of the carcinoma tissue specimens. CDtotal significantly correlated with the histological grade, PCNA index (PI), mitotic rate (MR), EGF-R and lymph node metastasis. Significant correlation was also demonstrated between CDpar and the histological grade, EGF-R and lymph node metastasis, or between CDstr and MR, EGF-R and lymph node metastasis. EGF-R correlated highly with the histological grade, MR score, lymph node metastases and recurrence-free survival.
Conclusions:
Both the CD parameters and EGF-R are valuable indicators for predicting the biological behaviour of human breast carcinoma. 相似文献
997.
998.
Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice 总被引:2,自引:0,他引:2
Anne Bourson Véronique Kapps Catherine Zwingelstein Alain Rudler Frank G. Boess A. J. Sleight 《Naunyn-Schmiedeberg's archives of pharmacology》1997,356(6):820-826
Audiogenic seizures can be induced in DBA/2J mice following intense auditory stimulation. A number of neurotransmitters, including
5-hydroxytryptamine (5-HT), are believed to be involved in mediating this effect since it has been shown previously that depletion
of 5-HT or blockade of 5-HT receptors protects DBA/2J mice from these audiogenic seizures. The present study was undertaken
to determine whether antagonism of the newly identified 5-HT7 receptor may protect DBA/2J mice from audiogenic seizures by attempting to correlate in vivo potency of compounds with their
affinity at the 5-HT7 receptor. All compounds used in the correlation were shown to be antagonists at the 5-HT7 receptor and a statistically significant correlation was observed between 5-HT7 affinity and doses for half-maximal response (ED50) for protection of DBA/2J mice from sound-induced seizures (r = 0.80; P < 0.05). No significant correlation was observed between in vivo activity and affinity at either 5-HT1A, 5-HT2A or 5-HT2C receptors. It is also unlikely that interactions between the 5-ht5 receptor will protect DBA/2J mice from audiogenic seizures since metergoline and mesulergine which are both active in this
in vivo model have no affinity for the 5-ht5 receptor. There are similarities between the pharmacology of the 5-HT7 receptor and that of the 5-HT1A receptor, however the correlation between the in vivo potency in DBA/2J mice and 5-HT1A affinity was not significant. Furthermore, the 5-HT1A receptor antagonist WAY 100135 did not protect DBA/2J mice from audiogenic seizures at doses that antagonise 5-HT1A receptor-mediated effects in mice. These data suggest that antagonism of 5-HT7 receptors may protect against audiogenic seizures in DBA/2J mice although a definitive conclusion must await studies with
selective 5-HT7 antagonists.
Received: 20 March 1997 / Accepted: 10 August 1997 相似文献
999.
S. Bereswill F. Fassbinder C. Völzing A. Covacci R. Haas M. Kist 《Medical microbiology and immunology》1998,186(4):177-187
Various strains of Helicobacter pylori were able to lyse erythrocytes from sheep, horse, and human when grown on blood agar. The hemolysis did not depend on the
production of the vacuolating cytotoxin VacA as demonstrated by the hemolytic behavior of an isogenic vacA-negative mutant strain. The hemolytic activity could be detected in cell-free supernatants and was not regulated by iron.
To isolate genes coding for proteins involved in the destruction of erythrocytes, a plasmid-based DNA library was screened
for expression of lytic activity on blood agar. This approach revealed that the H. pylori ribA gene confers hemolytic properties to Escherichia coli. The ribA gene encodes the enzyme GTP-cyclohydrolase II [EC 3.5.4.25] that catalyzes the initial step in the synthesis of riboflavin.
The predicted amino acid sequence of the H. pylori RibA protein showed a high degree of similarity to equivalent enzymes from microorganisms and from plants. The single gene
on a plasmid restored riboflavin synthesis in a ribA mutant of E. coli and induced hemolytic activity. Furthermore, ribA overexpression was associated with the production of a fluorescent yellow molecule that was not identical with riboflavin.
Hemolysis was also seen for the ribA gene from E. coli, indicating that this feature was not specific for the H. pylori gene. The presence of ribA in various H. pylori strains was confirmed by Southern blot hybridization and by polymerase chain reaction with specific primers. This analysis
revealed that microdiversity exists within the DNA region upstream from ribA, which was further confirmed by nucleotide sequence analysis.
Received: 25 July 1997 相似文献
1000.